CA Patent

CA2446356C — Use of compositions for treating rosacea

Assigned to University of Michigan System · Expires 2012-07-10 · 14y expired

What this patent protects

Rosacea is treated with a composition comprising an antimicrobial and at least one of an anti-inflammatory and a non-retinoid inhibitor of at least one of NF-K.beta., AP-1, MMPs, adhesion molecules, TLRs, and CD14. The composition may further comprise a retinoid.

USPTO Abstract

Rosacea is treated with a composition comprising an antimicrobial and at least one of an anti-inflammatory and a non-retinoid inhibitor of at least one of NF-K.beta., AP-1, MMPs, adhesion molecules, TLRs, and CD14. The composition may further comprise a retinoid.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2446356C
Jurisdiction: CA
Classification: —
Expires: 2012-07-10
Drug substance claim: No
Drug product claim: No
Assignee: University of Michigan System
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.